share_log

Adial Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Anderson J. Kermit

Adial Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities

Adial Pharmaceuticals | 4：持股變動聲明
美股SEC公告 ·  03/28 06:10
牛牛AI助理已提取核心訊息
Adial Pharmaceuticals, Inc. (ADIL) has reported a transaction involving Anderson J. Kermit, a reporting person associated with the company. The transaction took place on March 25, 2024. However, the details regarding the nature of the transaction, such as the number of shares traded, the transaction price, and the resulting ownership stake, have not been disclosed. Investors are advised to await further information to fully assess the impact of this event on their investment decisions.
Adial Pharmaceuticals, Inc. (ADIL) has reported a transaction involving Anderson J. Kermit, a reporting person associated with the company. The transaction took place on March 25, 2024. However, the details regarding the nature of the transaction, such as the number of shares traded, the transaction price, and the resulting ownership stake, have not been disclosed. Investors are advised to await further information to fully assess the impact of this event on their investment decisions.
Adial Pharmicals, Inc.（ADIL）報告了一筆涉及與該公司有關聯的舉報人安德森·柯米特的交易。該交易於 2024 年 3 月 25 日進行。但是，有關交易性質的細節，例如交易的股票數量、交易價格以及由此產生的所有權，尚未披露。建議投資者等待進一步的信息，以全面評估該事件對其投資決策的影響。
Adial Pharmicals, Inc.（ADIL）報告了一筆涉及與該公司有關聯的舉報人安德森·柯米特的交易。該交易於 2024 年 3 月 25 日進行。但是，有關交易性質的細節，例如交易的股票數量、交易價格以及由此產生的所有權，尚未披露。建議投資者等待進一步的信息，以全面評估該事件對其投資決策的影響。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。